Product
MDR
1 clinical trial
1 indication
Indication
Immune ToleranceClinical trial
Extension Study to Assess the Long-Term Safety in Recipients Who Previously Received Medeor's Cellular Immunotherapy ProductsStatus: Recruiting, Estimated PCD: 2031-12-01